Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Lancet. Respiratory Medicine|March 30, 2018
Safety and immunogenicity of the novel tuberculosis vaccine ID93 + GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trialAdam Penn-Nicholson, Michele Tameris, Erica Smit, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 15, 2025
Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosisHumphrey Mulenga, Justin Shenje, Simon C Mendelsohn, et al.
The Lancet. Respiratory Medicine|August 17, 2019
Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trialMichele Tameris, Helen Mearns, Adam Penn-Nicholson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2019
Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tubeElisa Nemes, Deborah Abrahams, Thomas J Scriba, et al.
American Journal of Respiratory and Critical Care Medicine|July 25, 2017
Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis InfectionElisa Nemes, Virginie Rozot, Hennie Geldenhuys, et al.
Frontiers in Microbiology|July 13, 2019
Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral TherapyFatoumatta Darboe, Stanley Kimbung Mbandi, Kogieleum Naidoo, et al.
The New England Journal of Medicine|July 12, 2018
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG RevaccinationElisa Nemes, Hennie Geldenhuys, Virginie Rozot, et al.
Ebiomedicine|March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic settingMichele Tameris, Virginie Rozot, Claire Imbratta, et al.
The Lancet. Global Health|April 18, 2025
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trialAngelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta, et al.
The Journal of Infectious Diseases|April 9, 2020
Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed ControlsSara Suliman, Anele Gela, Simon C Mendelsohn, et al.
Pageof 4